Insider Shareholders with Direct Ownership of Biocryst Pharmaceuticals Inc (BCRX)
This section provides a comprehensive overview of the insiders with direct ownership of Biocryst Pharmaceuticals Inc (BCRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOCRYST PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jon P Stonehouse
Chief Executive Officer |
1,517,006 | 993,328 | 1,323,429 $9.37 Million | 29 |
Dec 19, 2025
Reduced 4.46%
|
|
Charles K Gayer
President and CCO |
894,183 | 44,792 | 952,583 $6.74 Million | 14 |
Dec 22, 2025
Added 4.99%
|
|
Alane P Barnes
Chief Legal Officer |
677,518 | 382,113 | 398,751 $2.82 Million | 26 |
Dec 22, 2025
Reduced 5.18%
|
|
Anthony Doyle
Chief Financial Officer |
375,258 | 24,008 | 377,867 $2.68 Million | 11 |
Dec 19, 2024
Reduced 0.65%
|
|
Helen M. Thackray
Chief R&D Officer |
431,950 | 54,632 | 377,318 $2.67 Million | 15 |
Mar 31, 2025
Reduced 1.96%
|
|
Yarlagadda S Babu
Chief Discovery Officer |
247,000 | 104,046 | 298,541 $2.11 Million | 8 |
Nov 14, 2022
Reduced 9.55%
|
|
Babar Ghias
Chief Financial Officer |
268,700 | 0 | 268,700 $1.9 Million | 2 |
Dec 17, 2025
Added 31.17%
|
|
Robert Alexander Ingram
Director |
30,593 | 0 | 100,198 $709,401 | 11 |
Feb 28, 2023
Added 2.2%
|
|
Nancy J Hutson
Director |
184,022 | 148,199 | 99,138 $701,897 | 14 |
Jun 12, 2025
Added 11.2%
|
|
Vincent Milano
Director |
81,219 | 0 | 91,219 $645,830 | 20 |
Nov 28, 2025
Added 0.85%
|
|
Steve Aselage
Director |
41,546 | 0 | 70,159 $496,725 | 10 |
Jun 12, 2024
Added 8.86%
|
|
Kenneth B Lee Jr
Director |
59,611 | 6,000 | 68,863 $487,550 | 5 |
Jun 13, 2023
Added 19.56%
|
|
Theresa Heggie
Director |
129,642 | 76,698 | 65,352 $462,692 | 22 |
Aug 13, 2025
Reduced 51.72%
|
|
Alan G Levin
Director |
64,271 | 0 | 64,271 $455,038 | 13 |
Jun 12, 2025
Added 16.28%
|
|
Amy E Mc Kee
Director |
50,390 | 8,600 | 41,790 $295,873 | 7 |
Nov 28, 2025
Added 1.84%
|
|
William P Sheridan
Chief Medical Officer |
388,125 | 365,962 | 37,954 $268,714 | 9 |
Mar 10, 2022
Reduced 3.56%
|
|
George B Abercrombie
Director |
139,098 | 112,667 | 36,431 $257,931 | 18 |
Jun 12, 2024
Added 15.77%
|
|
Machelle Sanders
Director |
48,931 | 18,289 | 30,642 $216,945 | 7 |
Nov 13, 2025
Reduced 23.86%
|
|
Steven K Galson
Director |
70,871 | 0 | 24,991 $176,936 | 5 |
Jun 12, 2025
Added 33.34%
|
|
Steven Frank
Director |
17,618 | 0 | 17,618 $124,735 | 5 |
Nov 28, 2025
Added 8.16%
|
|
Michael L Jones
Exec. Director, Finance - PAO |
27,150 | 11,345 | 16,653 $117,903 | 8 |
Dec 19, 2022
Added 26.16%
|